McLaughlin Kevin F

SVP, CFO and TreasurerACCELERON PHARMA INC (XLRN) · full profile →Form 4 · filed Sep 24, 2021
Net Selling
Open-Market Buys
$0
Open-Market Sells
$4.0M
Net Open-Market Flow
-$4.0M
Transactions
13
8 non-derivative · 5 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 24, 2021Option exercise(M)5K$40.61$211K16K
Sep 24, 2021Sell(S)5K$160.38$861K11K
Sep 24, 2021Option exercise(M)170$41.64$7K16K
Sep 23, 2021Option exercise(M)7K$41.64$305K30K
Sep 23, 2021Sell(S)19K$160.26$3.0M12K
Sep 23, 2021Option exercise(M)3K$30.17$75K13K
Sep 23, 2021Option exercise(M)10K$40.61$398K23K
Sep 23, 2021Sell(S)983$161.26$159K11K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 24, 2021Option exercise(M)170$021K
Sep 24, 2021Option exercise(M)5K$011K
Sep 23, 2021Option exercise(M)10K$016K
Sep 23, 2021Option exercise(M)7K$021K
Sep 23, 2021Option exercise(M)3K$03K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001179110-21-008935) within minutes of acceptance. Every field above traces to the original document. Verify it directly: